Table 2.
Neurobiologic Mechanisms of ADHD.
| Anatomical correlates |
| Smaller total brain volume (including frontal lobe, caudate nucleus, and cerebellum) |
| Reduced thickness of prefrontal and other cortical regions |
| Functional correlates |
| Alterations in connectivity in frontostriatal, frontoparietal, frontocerebellar, and parieto-occipital pathways and in the cingulate cortex |
| Decreased activity in the networks involved with executive function and with attention, and increased activity in the default mode network, which is deactivated during cognitive tasks and is implicated in mind wandering and interoception |
| Delayed brain maturation |
| Neurochemical factors |
| Dysregulation of dorsal striatal and ventral striatal dopamine systems |
| Dysregulation of noradrenaline systems |
| Genetic risk factors |
| Heritability of approximately 0.8 |
| At least 18 ADHD-susceptibility genes (including the dopamine receptors D4 (DRD4) and D5, dopamine transporter (DAT1), serotonin receptor 1B, and synaptosomal-associated protein 25), but without specificity; 7-repeat allele of DRD4 most strongly implicated |
| Small effect sizes in molecular genetic analyses and genomewide association studies |
| Environmental and clinical risk factors |
| Prenatal exposure to alcohol, tobacco, and lead |
| Complications of pregnancy and birth |
| Neonatal anoxia, seizures, and brain injury |
| Obesity and diabetes |
| Gene–environment interactions |
| Interaction between genetic variants (DRD4 and DAT1) and environmental factors such as maternal smoking during pregnancy |